Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers
-
Published:2023-09
Issue:
Volume:191
Page:112981
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Borcoman Edith,
Lalanne Ana,
Delord Jean-Pierre,
Cassier Philippe A.,
Rolland FrédéricORCID,
Salas Sébastien,
Limacher Jean-MarcORCID,
Capitain Olivier,
Lantz OlivierORCID,
Ekwegbara Christina,
Jeannot EmmanuelleORCID,
Cyrta JoannaORCID,
Tran-Perennou Carine,
Castel-Ajgal Zahra,
Marret GrégoireORCID,
Piaggio Eliane,
Brandely Maud,
Tavernaro Annette,
Makhloufi Hakim,
Bendjama KaidreORCID,
Le Tourneau ChristopheORCID
Subject
Cancer Research,Oncology
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献